• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock (NQ:XOMAP)

    25.75 -0.05 (-0.19%)
    Streaming Delayed Price Updated: 12:20 PM EDT, Mar 19, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,108
    Open 25.87
    Bid (Size) 25.27 (100)
    Ask (Size) 26.08 (100)
    Prev. Close 25.80
    Today's Range 25.75 - 25.87
    52wk Range 24.96 - 30.00
    Shares Outstanding N/A
    Dividend Yield 8.37%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    XOMA Royalty Declares Quarterly Preferred Stock Dividends
    From XOMA Royalty Corporation
    Via GlobeNewswire
    News headline image
    XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements
    From XOMA Royalty Corporation
    Via GlobeNewswire

    Performance

    YTD
    -5.0%
    -5.0%
    1 Month
    -1.9%
    -1.9%
    3 Month
    -3.1%
    -3.1%
    6 Month
    -3.0%
    -3.0%
    1 Year
    +0.7%
    +0.7%

    More News

    Read More
    News headline image
    XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
    From XOMA Royalty Corporation
    Via GlobeNewswire
    News headline image
    XOMA Royalty to Present at Investor Conferences in March
    From XOMA Royalty Corporation
    Via GlobeNewswire
    News headline image
    XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.
    From XOMA Royalty Corporation
    Via GlobeNewswire
    News headline image
    XOMA Royalty Announces CFO Transition
    From XOMA Royalty Corporation
    Via GlobeNewswire
    News headline image
    XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab
    From XOMA Royalty Corporation
    Via GlobeNewswire
    News headline image
    XOMA Royalty Declares Quarterly Preferred Stock Dividends
    From XOMA Royalty Corporation
    Via GlobeNewswire
    News headline image
    XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc
    From XOMA Royalty Corporation
    Via GlobeNewswire
    News headline image
    XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V.
    From XOMA Royalty Corporation
    Via GlobeNewswire
    News headline image
    XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements
    From XOMA Royalty Corporation
    Via GlobeNewswire
    News headline image
    XOMA Royalty and LAVA Therapeutics Announce Amendment to Purchase Agreement
    From XOMA Royalty Corporation; LAVA Therapeutics N.V.
    Via GlobeNewswire
    News headline image
    XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.
    From XOMA Royalty Corporation; LAVA Therapeutics
    Via GlobeNewswire
    News headline image
    XOMA Royalty Declares Quarterly Preferred Stock Dividends
    From XOMA Royalty Corporation
    Via GlobeNewswire
    News headline image
    XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc.
    From XOMA Royalty Corporation
    Via GlobeNewswire
    News headline image
    XOMA Royalty to Present at H.C. Wainwright 27th Annual Global Investment Conference
    From XOMA Royalty Corporation
    Via GlobeNewswire
    News headline image
    Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share
    From XOMA Royalty Corporation
    Via GlobeNewswire
    News headline image
    XOMA Royalty Reports Second Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements
    From XOMA Royalty Corporation
    Via GlobeNewswire
    News headline image
    XOMA Royalty Announces Closing of Tender Offer for Turnstone Biologics
    From XOMA Royalty Corporation
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Thursday's Intraday Session ↗
    Via Benzinga
    News headline image
    XOMA Royalty Enters into Agreement to Acquire LAVA Therapeutics for Between $1.16 and $1.24 Per Share in Cash, Plus a Contingent Value Right
    From XOMA Royalty Corporation; LAVA Therapeutics N.V.
    Via GlobeNewswire
    News headline image
    HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right
    From XOMA Royalty Corporation
    Via GlobeNewswire
    News headline image
    Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right
    From XOMA Royalty Corporation; Turnstone Biologics Corp.
    Via GlobeNewswire
    News headline image
    XOMA Royalty Declares Quarterly Preferred Stock Dividends
    From XOMA Royalty Corporation
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
    Via Benzinga

    Frequently Asked Questions

    Is XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock publicly traded?
    Yes, XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock is publicly traded.
    What exchange does XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock trade on?
    XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock?
    The ticker symbol for XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock is XOMAP on the Nasdaq Stock Market
    What is the current price of XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock?
    The current price of XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock is 25.75
    When was XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock last traded?
    The last trade of XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock was at 03/19/26 12:20 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.